Marshall Wace’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$503K Buy
92,819
+23,346
+34% +$107K ﹤0.01% 2516
2026
Q1
$262K Buy
69,473
+29,520
+74% +$159K ﹤0.01% 2696
2025
Q4
$317K Buy
+39,953
New +$255K ﹤0.01% 2429
2025
Q1
Sell
-26,300
Closed -$95.7K 3046
2024
Q4
$95.7K Buy
+26,300
New +$120K ﹤0.01% 2446
2024
Q1
Sell
-47,513
Closed -$245K 2775
2023
Q4
$245K Buy
+47,513
New +$147K ﹤0.01% 1927
2022
Q1
Sell
-100
Closed -$1K 3948
2021
Q4
$1K Buy
+100
New +$2.19K ﹤0.01% 3797

Other funds holding SGHT

Marshall Wace's SGHT Position: Q2 2026 in Review

Marshall Wace increased its Sight Sciences (SGHT) stake by 34% in Q2 2026, buying an estimated $107K and bringing the position to 92,819 shares worth $503K. The position accounts for ﹤0.01% of the portfolio, ranked #2516.

Marshall Wace first reported a position in SGHT in Q4 2021 and has held it in 6 quarters since. 112 funds tracked by Wall St. Rank hold SGHT as of Q2 2026.

  • Marshall Wace held 92,819 shares of Sight Sciences worth $503K as of Q2 2026.
  • Marshall Wace bought 23,346 Sight Sciences shares in Q2 2026, an estimated $107K.
  • Sight Sciences made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2516 holding.
  • Marshall Wace first reported a position in Sight Sciences in Q4 2021 and has held it in 6 quarters since.
  • 112 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.